C.R. BARD, INC. (BASD) -3006260740 POWERPORT CLEARVUE ISP IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
|
Back to Search Results |
|
Model Number 1608062 |
Device Problems
Loss of or Failure to Bond (1068); Fracture (1260); Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/28/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 07/2020).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that approximately three years and six months post port placement, a computed tomography revealed cylindrical calcific density in the left upper lobe segmental pulmonary artery, and was suspicious for an embolized catheter fragment.It was further reported that the port was removed and it was confirmed to be intact upon inspection.Reportedly, radiological analysis revealed that the radio density of the opacity in this patient's computed tomographic scan was not compatible with human tissue.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one powerport clearvue implantable port attached to a catheter was returned for evaluation.Gross visual, microscopic, tactile and functional evaluation were performed.The investigation is unconfirmed for the reported fracture and material separation issues as the port body was patent to both aspiration and infusion without issue.Also the investigation is inconclusive for the reported loss of or failure to bond as the exact circumstances at the time of the reported event was unknown.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 07/2020).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that approximately three years and six months post port placement, a computed tomography revealed cylindrical calcific density in the left upper lobe segmental pulmonary artery, and was suspicious for an embolized catheter fragment.It was further reported that the port was removed and it was confirmed to be intact upon inspection.Reportedly, radiological analysis revealed that the radio density of the opacity in this patient's computed tomographic scan was not compatible with human tissue.There was no reported patient injury.
|
|
Search Alerts/Recalls
|
|
|